Inhibition of macrophage iNOS by selective targeting of antisense PNA

Biochemistry

Volumn 41, Issue 26, 2002, Pages 8471-8477

  Chiarantini, Laura ^a   Cerasi, Aurora ^a   Fraternale, Alessandra ^a   Andreoni, Francesca ^a   Scarí, Sonia ^b   Giovine, Marco ^b   Clavarino, Emanuela ^b   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PERMEABILITY;

BIOMEDICAL ENGINEERING; DNA; RNA;

BIOCHEMISTRY;

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE NUCLEIC ACID; SUCCINIMIDE DERIVATIVE; ZINC CHLORIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; ENCAPSULATION; ENZYME INHIBITION; ERYTHROCYTE; MACROPHAGE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DNA, ANTISENSE; ERYTHROCYTES; HUMANS; KINETICS; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE NUCLEIC ACIDS; PHAGOCYTOSIS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

ANIMALIA; MURINAE;

EID: 0037007998     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi020079f     Document Type: Article

References (44)

1. Secretory products of macrophages
2. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release
3. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis
4. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line
5. Nitric oxide as a secretory product of mammalian cells
6. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
7. Expression and Detection of Inducible Nitric Oxide Synthase in Experimental Models of Inflammation
8. Nitric oxide and macrophage function
9. Nitric oxide and inflammatory arthritides
10. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line
11. Synthesis and characterization of a specific peptide nucleic acid that inhibits expression of inducible NO synthase
12. Current concepts in antisense drug design
13. Antisense oligonucleotides: Is the glass half full or half empty?
14. Synthetic oligonucleotides as therapeutics: The coming of age
15. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide
16. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules
17. Antisense and antigene properties of peptide nucleic acids
18. Automated detection of point mutations by electrophoresis in peptide-nucleic acid-containing gels
19. Antisense properties of duplex- and triplex-forming PNAs
20. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription
21. Sequence specific inhibition of DNA restriction enzyme cleavage by PNA
22. Phospholipid membrane permeability of peptide nucleic acid
23. Optimized recirculation survival of mouse carrier erythrocytes
24. In vitro targeting of erythrocytes to cytotoxic T-cells by coupling of Thy-1.2 monoclonal antibody
25. Modulated red blood cell survival by membrane protein clustering
26. Targeting dexamethasone to macrophages
27. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis
28. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages
29. Solid-phase synthesis of peptide nucleic acids
30. A p-methylbenzhy- drylamine resin for improved solid-phase synthesis of peptide amides
31. Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase
32. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies
33. In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity
34. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
35. Protein measurement with the folin phenol agent
36. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides
37. Peptide nucleic acids: On the road to new gene therapeutic drugs
38. Stability of peptide nucleic acids in human serum and cellular extracts
39. Interaction of the human NF-kappaβ p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaβ binding sites of the human immunodeficiency virus type 1 promoter
40. Improved metabolic properties of hexokinase-overloaded human erythrocytes
41. Red blood cells as a delivery system for AZT
42. Human Red Blood Cells (RBC) as bioreactors for the production and the release of fluoropyrimidine drugs from encapsulated pro-drugs
43. Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin